CARDIOTOXICITY
Clinical trials for CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Exercise may protect hearts of childhood cancer survivors
Disease control OngoingThis study looks at whether different levels of exercise can help the hearts of young adults who survived childhood cancer and were treated with a type of chemotherapy called anthracyclines. About 20 survivors aged 18-39 will take part. The goal is to see if exercise can reduce h…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Heart risks of breast cancer drugs under the microscope
Knowledge-focused OngoingThis study follows 200 women with breast cancer who are receiving doxorubicin and/or trastuzumab to see how these drugs affect heart function over time. Researchers will use echocardiograms, blood tests, and surveys to track changes and explore links to medical history and social…
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 05:01 UTC
-
Lung cancer Treatment's hidden heart risk under the microscope
Knowledge-focused OngoingThis study follows 221 people with stage II or III lung cancer to see how chemoradiation therapy affects their hearts. Participants get heart scans and blood tests before, during, and for two years after treatment. The goal is to better understand and track heart damage caused by…
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 05:00 UTC
-
Exercise test may spot heart risks in breast cancer patients
Knowledge-focused OngoingThis study looks at whether a cardiopulmonary exercise test (CPET) can help predict heart and lung function in women with HER2-positive breast cancer who have mild heart problems from their treatment. About 23 women will do a special exercise test to measure oxygen use. The goal …
Matched conditions: CARDIOTOXICITY
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:00 UTC
-
New study checks if cancer immunotherapy harms the heart
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how immune checkpoint inhibitors, a type of immunotherapy for cancer, affect the tiny blood vessels in the heart. Researchers will use heart scans and blood tests in 25 adults with breast or lung cancer before and during treatment. The goal is to understand if…
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC
-
Prostate cancer Treatment's hidden heart risk under the microscope
Knowledge-focused OngoingThis study watches 200 men with prostate cancer who are getting hormone therapy (androgen deprivation therapy) to see how it affects their heart health. Researchers will use heart ultrasounds, blood tests, and surveys to track changes and look at how factors like race, income, an…
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Smartwatches keep watch on heart risks for leukemia patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 50 adults with chronic lymphocytic leukemia who are starting certain drugs (acalabrutinib or zanabrutinib). These drugs can cause high blood pressure and irregular heartbeats. Participants will use wearable devices at home to track their heart rhythm and blood …
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
Smart patch could replace needle for heart check
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests if a wearable sensor can accurately estimate the heart's pumping ability (LVEF) in 50 adults who are already scheduled for an echocardiogram. The goal is to see if the sensor matches the standard ultrasound test. If successful, this could lead to easier, more fre…
Matched conditions: CARDIOTOXICITY
Sponsor: Skribe Medical • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC